Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxfendazole versus placebo for trichuriasis, mansonellosis, onchocerciasis, and loiasis in adults
PACTR202412611774752Phase 2Not yet recruiting
- Sponsor
- University of Buea
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised trial of oxfendazole in trichuriasis, Mansonelliasis, onchocerciasis and 1 more (12 arms), sponsored by University of Buea. Primary endpoints: Safe and efficient dose identification for each indication, Parasite load at day 18 for trichuriasis and 1 more. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
oxfendazole
03
Conditions
trichuriasisMansonelliasisonchocerciasisloiasis
Beyond the preview
Go deeper on PACTR202412611774752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412611774752.